ArticleClinical and translational radiation oncology2022

High-dose-rate brachytherapy boost for elderly patients with intermediate to high-risk prostate cancer: 5-year clinical outcome of the PROSTAGE cohort.

Delphine Marotte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.